Everolimus 82293-0031
Product NDC
82293-0031- Manufacturer
- Novugen Pharma (usa) Llc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 30, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA219955
Need to source Everolimus? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Everolimus | 5 mg/1 |
Drug Class
Kinase Inhibitor [EPC]mTOR Inhibitor Immunosuppressant [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(3)
28 TABLET in 1 BOTTLE (82293-031-10)
4 BLISTER PACK in 1 CARTON (82293-031-21) / 7 TABLET in 1 BLISTER PACK (82293-031-20)
1 POUCH in 1 CARTON (82293-031-31) / 3 BLISTER PACK in 1 POUCH / 10 TABLET in 1 BLISTER PACK (82293-031-30)